IDEXX Laboratories Analyst Price Targets - Benzinga

IDEXX Laboratories Inc

IDXXNASDAQ

Trade with Public

Trade with Public

$700.16

28.124.18%

最終更新: Nov 4, 3:47 PM

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

© 2026 Benzinga | All Rights Reserved

IDEXX Laboratories Analyst Price Targets

Wall Street analyst price targets and consensus rating for IDEXX Laboratories (IDXX).

Price Target Range — 13 Quarters

Analyst Consensus — 11 Analysts

7Buy

4Hold

Consensus RatingNeutral# Analysts11Avg. Consensus PT$665Upside to Avg. PT-5.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Nov 3, 2026	Morgan Stanley	Erin Wright	PT Raise	Overweight	$805→$810
Nov 3, 2026	UBS	Andrea Alfonso	PT Raise	Neutral	$627→$700
Oct 30, 2026	BTIG	Mark Massaro	Suspends	Buy	—
Oct 27, 2026	UBS	Andrea Alfonso	PT Cut	Neutral	$670→$627
Oct 16, 2026	JP Morgan	Chris Schott	PT Cut	Overweight	$775→$750
Oct 12, 2026	Keybanc	Steve Dechert	Initiate	Sector Weight	—
Aug 11, 2026	Barclays	Glen Santangelo	PT Cut	Overweight	$800→$710
Aug 5, 2026	UBS	Andrea Alfonso	PT Raise	Neutral	$620→$670
Aug 5, 2026	Citigroup	Daniel Grosslight	PT Raise	Neutral	$650→$670
Jul 27, 2026	UBS	Andrea Alfonso	PT Cut	Neutral	$640→$620
Apr 28, 2026	UBS	Andrea Alfonso	PT Cut	Neutral	$730→$640
Apr 15, 2026	Citigroup	Daniel Grosslight	Initiate	Neutral	$650
Mar 31, 2026	Stifel	Jonathan Block	PT Cut	Buy	$775→$675
Feb 9, 2026	Piper Sandler	David Westenberg	PT Cut	Neutral	$775→$750
Feb 5, 2026	Barclays	Glen Santangelo	PT Cut	Overweight	$850→$800
Feb 3, 2026	UBS	Andrea Alfonso	PT Cut	Neutral	$750→$730
Feb 3, 2026	BTIG	Mark Massaro	PT Cut	Buy	$830→$800
Dec 9, 2025	Barclays	Glen Santangelo	Initiate	Overweight	$850
Nov 4, 2025	Morgan Stanley	Erin Wright	PT Raise	Overweight	$765→$805
Nov 4, 2025	UBS	Andrea Alfonso	PT Raise	Neutral	$710→$750

Analyst Ratings News

PRO
Morgan Stanley Maintains Overweight on IDEXX Laboratories, Raises Price Target to $810

Morgan Stanley analyst Erin Wright maintains IDEXX Laboratories (NASDAQ:IDXX) with a Overweight and raises the price target from $805 to $810.

Benzinga Newsdesk

PRO
UBS Maintains Neutral on IDEXX Laboratories, Raises Price Target to $700

UBS analyst Andrea Alfonso maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral and raises the price target from $627 to $700.

Benzinga Newsdesk

PRO
BTIG Suspends Buy Rating on IDEXX Laboratories

BTIG suspends Buy rating on IDEXX Laboratories (NASDAQ:IDXX).

Benzinga Newsdesk

PRO
UBS Maintains Neutral on IDEXX Laboratories, Lowers Price Target to $627

UBS analyst Andrea Alfonso maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral and lowers the price target from $670 to $627.

Benzinga Newsdesk

PRO
JP Morgan Maintains Overweight on IDEXX Laboratories, Lowers Price Target to $750

JP Morgan analyst Chris Schott maintains IDEXX Laboratories (NASDAQ:IDXX) with a Overweight and lowers the price target from $775 to $750.

Benzinga Newsdesk

This Robinhood Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Analysts initiated coverage on ASBH, QNRX, AXGN and HOOD with bullish ratings and targets; IDXX received a Sector Weight rating.

Avi Kapoor